Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Thomas Berger (Vienna, Austria) Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(218)

Populärt inom Vetenskap

dumma-manniskor
p3-dystopia
rss-mottagningen
allt-du-velat-veta
rss-ronden
kapitalet-en-podd-om-ekonomi
det-morka-psyket
medicinvetarna
bildningspodden
rss-kriminologerna
ufo-sverige
rss-ufobortom-rimligt-tvivel
sexet
rss-vetenskapsradion
rss-spraket
rss-geopodden-2
halsorevolutionen
paranormalt-med-caroline-giertz
svd-nyhetsartiklar
dumforklarat